Clinical Trial Update: Circulating miRNAs as Biomarkers of Hormone Sensitivity in Breast Cancer [Phase 4]

View source ↗

Summary

This clinical trial update discusses circulating microRNAs as biomarkers for hormone sensitivity in breast cancer. The Phase 4 study is complete.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Snippet

Sponsor: Institut Claudius Regaud | Conditions: Breast Cancer | Phase 4 | Status: COMPLETED